Aberdeen Group plc Purchases 172,280 Shares of Tempus AI, Inc. $TEM

Key Points

• Aberdeen Group plc has increased its holdings in Tempus AI, acquiring an additional 172,280 shares in the first quarter, resulting in a total of 254,730 shares valued at approximately $12.3 million.
• Tempus AI reported a revenue of $314.64 million in its latest quarterly earnings, significantly exceeding analysts' expectations and marking an 89.5% year-over-year growth.
• Insider sales at Tempus AI included CEO Eric P. Lefkofsky selling 250,000 shares valued at $17.5 million, reflecting a 2.60% decrease in his ownership.

Aberdeen Group plc boosted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 209.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 254,730 shares of the company's stock after buying an additional 172,280 shares during the period. Aberdeen Group plc owned about 0.15% of Tempus AI worth $12,288,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in TEM. Cherry Tree Wealth Management LLC acquired a new position in shares of Tempus AI in the first quarter valued at $31,000. University of Texas Texas AM Investment Management Co. bought a new position in Tempus AI during the 1st quarter worth $33,000. Bartlett & CO. Wealth Management LLC boosted its stake in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after buying an additional 400 shares in the last quarter. Nemes Rush Group LLC acquired a new position in shares of Tempus AI in the first quarter worth approximately $39,000. Finally, Continuum Advisory LLC acquired a new position in shares of Tempus AI during the first quarter worth approximately $39,000. Institutional investors own 24.22% of the company's stock.

Tempus AI Price Performance

Shares of Tempus AI stock traded down $5.37 during trading on Tuesday, hitting $73.08. 12,658,702 shares of the company were exchanged, compared to its average volume of 10,771,664. The firm has a 50 day moving average price of $63.43 and a 200 day moving average price of $58.88. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The stock has a market capitalization of $12.70 billion, a price-to-earnings ratio of -61.41 and a beta of 4.98. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The firm had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. During the same period in the prior year, the company earned ($6.86) EPS. The firm's revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. On average, equities analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on TEM. Bank of America boosted their price objective on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. BTIG Research initiated coverage on Tempus AI in a research note on Friday, August 8th. They set a "buy" rating and a $60.00 price target for the company. Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Morgan Stanley boosted their price objective on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 12th. Finally, Needham & Company LLC restated a "buy" rating and set a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $65.36.

Insider Activity

In related news, Director Theodore Leonsis sold 44,000 shares of Tempus AI stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $69.90, for a total value of $3,075,600.00. Following the transaction, the director owned 86,756 shares in the company, valued at $6,064,244.40. This trade represents a 33.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Erik Phelps sold 51,317 shares of the firm's stock in a transaction on Monday, June 16th. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52. Following the completion of the sale, the executive vice president owned 97,779 shares in the company, valued at $7,094,844.24. This represents a 34.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 723,039 shares of company stock valued at $49,035,482 in the last ninety days. 27.60% of the stock is owned by company insiders.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.